Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shinya Tanaka

Showing results (491-500 of 496) with videos related to

Pageof 50
Sort By:
You have reached the last page of results.This site can display upto 496 results.
Nature|November 25, 2021
Enhanced fusogenicity and pathogenicity of SARS-CoV-2 Delta P681R mutationAkatsuki Saito, Takashi Irie, Rigel Suzuki, et al.
Nature Communications|May 16, 2023
Virological characteristics of the SARS-CoV-2 XBB variant derived from recombination of two Omicron subvariantsTomokazu Tamura, Jumpei Ito, Keiya Uriu, et al.
Cell Host & Microbe|October 22, 2022
Virological characteristics of the SARS-CoV-2 Omicron BA.2.75 variantAkatsuki Saito, Tomokazu Tamura, Jiri Zahradnik, et al.
Acta Neuropathologica|December 11, 2019
Pineoblastoma segregates into molecular sub-groups with distinct clinico-pathologic features: a Rare Brain Tumor Consortium registry studyBryan K Li, Alexandre Vasiljevic, Christelle Dufour, et al.
Microbiology and Immunology|July 4, 2024
Virological characteristics of the SARS-CoV-2 Omicron EG.5.1 variantShuhei Tsujino, Sayaka Deguchi, Tomo Nomai, et al.
Cell|May 14, 2022
Virological characteristics of the SARS-CoV-2 Omicron BA.2 spikeDaichi Yamasoba, Izumi Kimura, Hesham Nasser, et al.
Pageof 50

Showing results (491-500 of 496) with videos related to

Sort By:
Pageof 50
You have reached the last page of results.This site can display upto 496 results.
Nature|November 25, 2021
Enhanced fusogenicity and pathogenicity of SARS-CoV-2 Delta P681R mutationAkatsuki Saito, Takashi Irie, Rigel Suzuki, et al.
Nature Communications|May 16, 2023
Virological characteristics of the SARS-CoV-2 XBB variant derived from recombination of two Omicron subvariantsTomokazu Tamura, Jumpei Ito, Keiya Uriu, et al.
Cell Host & Microbe|October 22, 2022
Virological characteristics of the SARS-CoV-2 Omicron BA.2.75 variantAkatsuki Saito, Tomokazu Tamura, Jiri Zahradnik, et al.
Acta Neuropathologica|December 11, 2019
Pineoblastoma segregates into molecular sub-groups with distinct clinico-pathologic features: a Rare Brain Tumor Consortium registry studyBryan K Li, Alexandre Vasiljevic, Christelle Dufour, et al.
Microbiology and Immunology|July 4, 2024
Virological characteristics of the SARS-CoV-2 Omicron EG.5.1 variantShuhei Tsujino, Sayaka Deguchi, Tomo Nomai, et al.
Cell|May 14, 2022
Virological characteristics of the SARS-CoV-2 Omicron BA.2 spikeDaichi Yamasoba, Izumi Kimura, Hesham Nasser, et al.
Pageof 50